Full video transcriptClick to expand
Auto-generated transcript of @luvlouyim's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I recently had bioidentical hormone replacement therapy in the form of a testosterone pellet
- 0:05placed on yesterday and I want to share my experience with you.
- 0:09So back story, I went in towards the end of last year to my bi-annual GYN.
- 0:15I had symptoms of perimenopause menopause, which was hot flashes, night sweats, and itchiness
- 0:22and fatigue, trouble sleeping and expressed all of these things to my GYN at the time.
- 0:31She was totally dismissive, basically told me since I had a fully intact uterus and still
- 0:36get my period regularly, there was nothing she could do for me.
- 0:39So, I went online, I was utilizing an online service in which they have prescribed me
- 0:45estradial and progesterone.
- 0:48But hadn't done any lab work because the standard of care is that you typically don't
- 0:52have to do lab work, especially if you are a perimenopausal and having symptoms.
- 0:58That said, the fatigue was still there and on top of that, I just wanted my labs done.
- 1:04I want to be under the care of a doctor who has a baseline, who we can look at this baseline
- 1:11every single year or however long we need to look at it so that I can know how I'm transitioning
- 1:16into the next phase of life.
- 1:18The star is aligned, I found someone, she's a very smart woman, she has been a GYN for
- 1:26over 20 years, she specializes in integrative care and she loves women's health and she
- 1:33is a woman of color.
- 1:35So a couple of weeks ago, she did a very thorough lab work up on me and my labs came back yesterday.
- 1:43I went in to discuss.
- 1:45My sex hormones were pretty good, my hormone level, I mean my estrogen levels were around
- 1:51a little bit above 100, my FSH was around a 5.3 or something like that, but my T levels
- 1:59were a 19.
- 2:01So she says optimally, so someone in my situation, she would want my testosterone levels to be
- 2:09between 100 to 200.
- 2:13That said, there are some out there that say that is too high for a woman.
- 2:20Nonetheless, I am documenting my experience here on TikTok because I want to pay it forward.
- 2:27I have learned so much on TikTok about Perry and menopause and hormone replacement therapy.
- 2:33So I want to document this so that I can help someone else.
- 2:36Plus, it's like a mixed bag out there like you have some women that have really good experiences,
- 2:42you have some that have really bad experiences, some of them, I don't know if I really believe,
- 2:49and I don't know if it's because I wanted the therapy so bad that I want to believe in
- 2:52something.
- 2:53Some women complained about rage and voice deepening and clitoral growth, all things
- 3:01that can happen.
- 3:03Again, the point of being under someone's care who is an integrative specialist, who is
- 3:10a GYN, who knows their stuff is that what someone to go in in four weeks, she's going
- 3:15to check my labs again.
- 3:17Unfortunately, though, once the pellet is in, you can't take it out.
- 3:21So if I just have to suffer through it, but I'm going to be optimistic about the entire
- 3:26situation.
- 3:27Also, I was given a B12 injection and I was also given some other supplements to optimize the
- 3:35overall hormone replacement therapy experience.
- 3:39Having said all that, please share in the comments section if you've had pellets to size the wrong,
- 3:44but your dosage is and what's your experience been?
BHRT pellets for testosterone: what TikTok gets wrong
Quick answer
This creator is a perimenopausal woman with a measured total testosterone of 19 ng/dL who received a subcutaneous testosterone pellet targeting a provider-cited range of 100 to 200 ng/dL. She is concurrently using estradiol and progesterone prescribed through a separate online service, which means she is managing multiple hormone therapies across at least two providers, a coordination gap worth flagging. Follow-up labs are planned at four weeks, which aligns with standard monitoring timing, though pellet dosing cannot be adjusted mid-cycle if levels come back supraphysiologic.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For BHRT pellets for testosterone: what TikTok gets wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
BHRT pellets for testosterone: what TikTok gets wrong should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "BHRT pellets for testosterone: what TikTok gets wrong" from HerSoftLife. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This creator is a perimenopausal woman with a measured total testosterone of 19 ng/dL who received a subcutaneous testosterone pellet targeting a provider-cited range of 100 to 200 ng/dL.
The reason this review is not generic is the source wording and the canonical claim label "trt hrt bhrtpellets testosterone pellets." In this clip, the useful excerpt is: "I recently had bioidentical hormone replacement therapy in the form of a testosterone pellet placed on yesterday and I want to share my experience with you." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
This creator is a perimenopausal woman with a measured total testosterone of 19 ng/dL who received a subcutaneous testosterone pellet targeting a provider-cited range of 100 to 200 ng/dL.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- This creator is a perimenopausal woman with a measured total testosterone of 19 ng/dL who received a subcutaneous testosterone pellet targeting a provider-cited range of 100 to 200 ng/dL. She is concurrently using estradiol and progesterone prescribed through a separate online service, which means she is managing multiple hormone therapies across at least two providers, a coordination gap worth flagging. Follow-up labs are planned at four weeks, which aligns with standard monitoring timing, though pellet dosing cannot be adjusted mid-cycle if levels come back supraphysiologic.
- The Global Consensus Position Statement (Davis et al., 2019) recommends targeting the upper normal female range for testosterone, roughly 45 to 60 ng/dL, not the 100 to 200 ng/dL cited in this video.
- Testosterone therapy for women is not FDA-approved for any indication in the US, making all such prescriptions off-label with a correspondingly thinner evidence base.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The Global Consensus Position Statement (Davis et al., 2019) recommends targeting the upper normal female range for testosterone, roughly 45 to 60 ng/dL, not the 100 to 200 ng/dL cited in this video.
- Testosterone therapy for women is not FDA-approved for any indication in the US, making all such prescriptions off-label with a correspondingly thinner evidence base.
- Pellets are not recommended by the Menopause Society or the Endocrine Society as a preferred delivery method because absorption is inconsistent and the dose cannot be adjusted or stopped once inserted.
- Some androgenic side effects from testosterone, particularly voice deepening and clitoral growth, can be irreversible even after hormone levels return to normal, a risk that applies specifically when using non-adjustable delivery like pellets.
- This creator is receiving hormone therapy from at least two separate providers, her online estradiol and progesterone service and her new integrative GYN. Managing multiple hormone prescriptions across providers without coordinated oversight creates real clinical risk.
- Perimenopause symptom dismissal, particularly in women of color, is a documented gap in care (Avis et al., 2001, Psychosomatic Medicine), and her experience of being brushed off reflects a real and studied problem, not just a bad-luck encounter.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @luvlouyim actually say?
She's a perimenopausal woman whose gynecologist dismissed her symptoms because she still has her uterus and gets regular periods. She found a new provider who ran labs, found her testosterone at 19 ng/dL, and placed a subcutaneous pellet to bring her into what her doctor called an "optimal" range of 100 to 200 ng/dL. She acknowledged the pellet can't be removed if problems arise, mentioned potential side effects like rage, voice deepening, and clitoral growth, and said she's going back in four weeks for follow-up labs. She's documenting everything on TikTok to help other women in perimenopause.
She's being honest about uncertainty. She said herself, "I don't know if I really believe" some of the horror stories, and she's upfront that the irreversibility is a real concern. That kind of transparency is rare in this corner of social media.
Does the science back this up?
Some of it does. Low testosterone in women is real, it's measurable, and it's associated with fatigue, low libido, and mood changes. But the target range her doctor cited, 100 to 200 ng/dL, sits well above what most clinical guidelines consider appropriate for women.
The Global Consensus Position Statement on testosterone in women (Davis et al., 2019, Journal of Clinical Endocrinology and Metabolism) recommends targeting the upper end of the normal female physiologic range, which tops out around 45 to 60 ng/dL depending on the assay. A target of 100 to 200 ng/dL would push most women into a supraphysiologic range, which is where androgenic side effects become more likely, not just possible. The Endocrine Society's clinical practice guidelines echo this caution. Pellets specifically carry documented risks of dose variability. A 2018 study by Glaser and Dimitrakakis in Maturitas noted pellets produce less predictable serum levels than injections or gels, which matters a lot when reversibility isn't an option.
What did they get wrong (or right)?
She got several things right. Her original GYN dismissing perimenopausal symptoms in a woman with an intact uterus and regular periods is a documented gap in care. Research consistently shows women in perimenopause are undertreated, particularly women of color (Avis et al., 2001, Psychosomatic Medicine). Getting a full lab panel before starting therapy is the right call, and she pushed for it herself.
Where things get murkier is the target range. Saying 100 to 200 ng/dL is optimal for women is not supported by major endocrinology guidelines. That doesn't mean her doctor is wrong about everything, but it's a claim that deserves scrutiny, not just acceptance. The irreversibility point is the most clinically significant concern she raised, and she raised it correctly. Pellets dissolve over three to six months. If androgenic side effects appear, there is no extraction option. That's a meaningful risk that her framing as "I'll just have to suffer through it" somewhat undersells. Voice changes and clitoral growth can be permanent even after testosterone normalizes.
What should you actually know?
Testosterone therapy for women is legitimate medicine, but it is not FDA-approved for women in the United States. Everything being prescribed here is off-label. That's not automatically a problem, off-label prescribing is legal and common, but it means the evidence base is thinner and oversight is lighter. The 2019 Global Consensus Statement supports testosterone use in women for hypoactive sexual desire disorder, with less evidence for other symptoms like fatigue.
Pellets are also the delivery method with the most dose uncertainty. A 2019 review by Shifren in Menopause noted that pellets are not recommended by major professional societies precisely because of inconsistent absorption and inability to adjust or stop the dose. If you're considering testosterone therapy, gels and patches allow dose titration. Pellets do not. Anyone pursuing this path should ask their provider specifically why pellets over adjustable delivery methods, and get a clear answer, not a sales pitch.
- Ask for labs before starting and at four to six weeks after initiation
- Request the specific assay being used to measure testosterone, results vary significantly between immunoassay and mass spectrometry methods
- Understand that target ranges for women differ meaningfully from men's ranges
- Know that some androgenic side effects, particularly voice changes, may not fully reverse
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
HerSoftLife · TikTok creator
1.3K views on this video
#hrt #bhrtpellets #testosterone #pellets
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the global consensus position statement (davis et al., 2019) recommends?
The Global Consensus Position Statement (Davis et al., 2019) recommends targeting the upper normal female range for testosterone, roughly 45 to 60 ng/dL, not the 100 to 200 ng/dL cited in this video.
What does the video say about testosterone therapy for women?
Testosterone therapy for women is not FDA-approved for any indication in the US, making all such prescriptions off-label with a correspondingly thinner evidence base.
What does the video say about pellets?
Pellets are not recommended by the Menopause Society or the Endocrine Society as a preferred delivery method because absorption is inconsistent and the dose cannot be adjusted or stopped once inserted.
What does the video say about some?
Some androgenic side effects from testosterone, particularly voice deepening and clitoral growth, can be irreversible even after hormone levels return to normal, a risk that applies specifically when using non-adjustable delivery like pellets.
What does the video say about this creator?
This creator is receiving hormone therapy from at least two separate providers, her online estradiol and progesterone service and her new integrative GYN. Managing multiple hormone prescriptions across providers without coordinated oversight creates real clinical risk.
What does the video say about perimenopause symptom dismissal, particularly in women of color,?
Perimenopause symptom dismissal, particularly in women of color, is a documented gap in care (Avis et al., 2001, Psychosomatic Medicine), and her experience of being brushed off reflects a real and studied problem, not just a bad-luck encounter.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by HerSoftLife, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.